Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: Relationship to estrogen and progesterone receptor status

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 427-433

  Cioppi, Federica ^a   Simi, Lisa ^a   Luciani, Paola ^a   Petraglia, Felice ^b   Susini, Tommaso ^a   Cobellis, Luigi ^b   Serio, Mario ^a   Maggi, Mario ^a   Peri, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Endometrial cancer; Estrogen receptor; Matrix metalloproteinase; Progesterone receptor; Uteroglobin

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GELATINASE B; PROGESTERONE RECEPTOR; UTEROGLOBIN;

AGED; ARTICLE; CANCER STAGING; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MIDDLE AGED; PATHOLOGY;

AGED; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; UTEROGLOBIN;

EID: 3242756950     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.427     Document Type: Article

References (30)

1. Sherman ME: Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13: 295-308, 2000.
2. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S: Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58: 3526-3528, 1998. (Pubitemid 28376543)
3. Susini T, Massi D, Paglierani M, et al: Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adeonocarcinoma. Hum Pathol 32: 360-367, 2001. (Pubitemid 32378297)
4. Fujimoto J, Hori M, Ichigo S and Tamaya T: Antiestrogenic compounds inhibit estroge-induced expression of fibroblast growth factor family (FFGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells. Eur J Gynaecol Oncol 18:497-501,1997. (Pubitemid 27519419)
5. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S and Tamaya T: Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells. Cancer Lett 141: 63-71, 1999. (Pubitemid 29261722)
6. Mizumoto H, Saito T, Ashihara K, Nishimura M, Tanaka R and Kudo R: Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-α gene in endometrial carcinoma cells. Int J Cancer 100: 401-406, 2002.
7. Guccione M, Silbiger S, Lei J and Neugartn J: Estradiol up-regulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol 10: F164-F169, 2001.
8. Miele L, Cordella-Miele E, Mantile G, Peri A and Mukherjee AB: Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins. J Endocrinol Invest 17: 679-692, 1994.
9. Peri A, Cordella-Miele E, Miele L and Mukherjee AB: Tissue-specific expression of the gene coding for human Clara cell 10-kDa protein a phospholipase A2-inhibitory protein. J Clin Invest 92: 2099-2109, 1993. (Pubitemid 23333512)
10. Peri A, Cowan BD, Bhartiya D, et al: Expression of Clara cell 10-kDa gene in the human endometrium and its relationship to oavrian menstrual cycle. DNA Cell Biol 5: 495-503, 1994. (Pubitemid 24291403)
11. 2. Trends Pharmacol Sci 20: 162-170, 1999.
12. Marks F, Fustenberg G and Muller-Decker K: Metabolic targets of cancer chemoprevention: interruption of tumor development by inhibitors of arachidonic acid metabolism. Recent Results Cancer Res 151:45-67, 1999.
13. Thun MJ, Henley SJ and Patrono C: Non-steroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266, 2002. (Pubitemid 34196319)
14. Leyton J, Manyak MJ, Mukherjee AB, Miele L, Mantile G and Patierno SR: Recombinant uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium. Cancer Res 54: 3696-3699, 1994. (Pubitemid 24241181)
15. Kundu GC, Mandal AK, Zhang Z, Mantile-Selvaggi G and Mukherjee AB: Uteroglobin (UG) suppresses extracellular matrix invasion by normal and cancer cells that express the high affinity UG-binding proteins. J Biol Chem 273: 22819-22824, 1998. (Pubitemid 28399857)
16. Kundu GC, Mantile G, Miele L, Cordella-Miele E and Mukherjee AB: Recombinant human uteroglobin suppresses cellular invasiveness via a novel class of high-affinity cell surface binding sites. Proc Natl Acad Sci USA 93: 2915-2919, 1996. (Pubitemid 26116247)
17. Szabo E, Goheer A, Witschi H and Linnoila RI: Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ 9: 475-485, 1998. (Pubitemid 28345872)
18. Zhang Z, Kundu GC, Panda D, et al: Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene. Proc Natl Acad Sci USA 96: 3963-3968, 1999. (Pubitemid 29169019)
19. Broers JL, Jensen SM, Travis WD, et al: Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridisation. Lab Invest 66: 337-346, 1992.
20. Linnoila RI, Jensen SM, Steinberg SM, Mulshine JL, Eggleston JC and Gazdar AF: Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. Am J Clin Pathol 97: 233-243, 1992.
21. Ernst T, Hergenhahn M, Kenzelman M, et al: Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol 160: 2169-2180, 2002. (Pubitemid 34663408)
22. Weeraratna AT, Cajigas JA, Schwartz A, Enquist EG, Manyak MJ and Patierno SR: Loss of uteroglobin expression in prostate cancer: relationship to advancing grade. Clin Cancer Res 3: 2295-2300, 1997. (Pubitemid 28133148)
23. Peri A, Bonaccorsi L, Muratori M, et al: Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. Int J Cancer 88: 525-534, 2000.
24. Maggi M, Bonaccorsi L, Finetti G, et al: Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. Cancer Res 54: 4777-4784, 1994. (Pubitemid 24276512)
25. FIGO stages: 1988 revisions: vulva, ovary, corpus. Gynecol Oncol 35: 125-127, 1989.
26. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocianate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
27. Fiorelli G, Picariello L, Martineti V, Tonelli F and Brandi ML: Functional estrogen receptor β in colon cancer cells. Biochem Biophys Res Commun 261: 521-527, 1999. (Pubitemid 29392509)
28. Dveksler GS, Basile AA and Dieffenbach CW: Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR Methods Appl 1: 283-285, 1992.
29. Bustin SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29: 23-39, 2002.
30. Manyak MJ, Kikukawa T and Mukherjee AB: Expression of uteroglobin-like protein in human prostate. J Urol 140: 176-182, 1988.